A Review on Quantitative Process Analytical Technology for Continuous Downstream Processing of Monoclonal Antibodies

Area of Science:

• Biopharmaceutical Manufacturing
• Process Analytical Technology
• Analytical Chemistry

Background:

• Increasing competition in the biopharmaceutical market necessitates cost-effective and efficient production methods.
• Rising research and development costs drive the need for innovative manufacturing strategies.
• Biosimilar market entry intensifies competition, demanding improved production economics.

Purpose of the Study:

• To review state-of-the-art quantitative real-time analytical techniques for monoclonal antibody characterization.
• To highlight opportunities for Process Analytical Technology (PAT) in continuous downstream biomanufacturing.
• To explore the benefits of PAT in reducing production cycle times and costs.

Main Methods:

• Literature review of current applications of PAT in biopharmaceutical manufacturing.
• Evaluation of real-time analytical techniques for in-process control and quality measurement.
• Analysis of PAT implementation for continuous downstream processing of monoclonal antibodies.

Main Results:

• Continuous manufacturing offers significant potential for reducing production cycle times and costs.
• Process Analytical Technology (PAT) enables in situ, real-time testing, replacing traditional batch testing.
• Active monitoring and control systems are crucial for quantitative product quality measurements in continuous processes.

Conclusions:

• Process Analytical Technology (PAT) is a robust strategy for real-time analytics in continuous biomanufacturing.
• Quantitative real-time analytical techniques are essential for characterizing monoclonal antibodies in continuous downstream processes.
• Future opportunities exist in advancing PAT for enhanced efficiency and quality control in biopharmaceutical production.